Related references
Note: Only part of the references are listed.Autologous hematopoietic cell transplantation for multiple sclerosis: a systematic review
James T. Reston et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Long-term results of stem cell transplantation for MS A single-center experience
A. Fassas et al.
NEUROLOGY (2011)
High-dose immunoablation with autologous haematopoietic stem cell transplantation in aggressive multiple sclerosis: a single centre 10-year experience
Eva Krasulova et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
The relation between inflammation and neurodegeneration in multiple sclerosis brains
Josa M. Frischer et al.
BRAIN (2009)
Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis a phase I/II study. (vol 8, pg 244, 2009)
R. K. Burt et al.
LANCET NEUROLOGY (2009)
Early highly aggressive MS successfully treated by hematopoietic stem cell transplantation
J. Fagius et al.
MULTIPLE SCLEROSIS (2009)
The challenge of follow-on biologics for treatment of multiple sclerosis
S. C. Reingold et al.
NEUROLOGY (2009)
Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study
Richard K. Burt et al.
LANCET NEUROLOGY (2009)
Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis
M. C. Vonk et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation as a treatment option in multiple sclerosis
Yury L. Shevchenko et al.
EXPERIMENTAL HEMATOLOGY (2008)
Bone-marrow transplantation fails to halt intrathecal lymphocyte activation in multiple sclerosis
T. Mondria et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis
Birgit Obermeier et al.
NATURE MEDICINE (2008)
Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome
Vk Kimiskidis et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study
L. Roccatagliata et al.
MULTIPLE SCLEROSIS (2007)
High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study
Richard A. Nash et al.
BLOOD (2007)
Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis - Long-term followup of a prospective clinical trial
D. M. C. Brinkman et al.
ARTHRITIS AND RHEUMATISM (2007)
Autologous hematopoietic stem cell transplantation for very active relapsing-remitting multiple sclerosis: report of two cases
E. Portaccio et al.
MULTIPLE SCLEROSIS JOURNAL (2007)
Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis
Imke Metz et al.
BRAIN (2007)
Autologous stem cell transplantation for progressive multiple sclerosis: Update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database
R. Saccardi et al.
MULTIPLE SCLEROSIS (2006)
Autologous peripheral blood stem cell transplantation for severe multiple sclerosis
Li Su et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2006)
Brain atrophy after immunoablation and stem cell transplantation in multiple sclerosis
J. T. Chen et al.
NEUROLOGY (2006)
Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus
RK Burt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Intense T cell depletion followed by autologous bone marrow transplantation for severe multiple sclerosis
JPA Samijn et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis
GL Mancardi et al.
MULTIPLE SCLEROSIS (2005)
Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis -: A consensus statement
MS Freedman et al.
ARCHIVES OF NEUROLOGY (2005)
Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life
R Saccardi et al.
BLOOD (2005)
Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases)
J Storek et al.
CLINICAL IMMUNOLOGY (2004)
Stem cell transplantation for multiple sclerosis: What is the evidence?
A Fassas et al.
BLOOD REVIEWS (2003)
Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation-based conditioning regimen to prevent disease progression in patients with high disability scores
RK Burt et al.
BLOOD (2003)
High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis
RA Nash et al.
BLOOD (2003)
Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases
RA Nash et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor
H Openshaw et al.
NEUROLOGY (2000)
Conditioning regimens for the treatment of experimental arthritis with autologous bone marrow transplantation
DW van Bekkum
BONE MARROW TRANSPLANTATION (2000)
Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: Report of toxicity and immunological monitoring
H Openshaw et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2000)
Share Paper
